Linguagen Corp., a developer of ingredients used to improve the taste of food, beverages and pharmaceutical products, announced the appointment of Scott M. Horvitz to the position of chief financial officer. Horvitz is a seasoned executive with more than 23 years experience in accounting and financial management of biotechnology companies, including the management of initial public offerings for two biotechnology companies with which he was affiliated. He is experienced in a broad spectrum of key strategic areas including: finance, SEC reporting, investor relations, corporate governance, budgeting, contract negotiation, mergers and acquisitions, business development, facilities and human resources.
"We are pleased to have someone with Scott's qualifications on board to help manage Linguagen's growth," said F. Raymond Salemme, chief executive officer, Linguagen Corp. "I know from working with Scott in the past that the depth and breadth of his capabilities in biotech finance and management make him a valuable addition to our senior management team. We all look forward to working with Scott to make Linguagen a very successful company."
Prior to joining Linguagen, Horvitz was a co-founder of 3-Dimensional Pharmaceuticals Inc., where he worked from its inception in 1993 until its acquisition by Johnson & Johnson in 2003, most recently serving as its chief financial officer and corporate secretary and treasurer. From 1991 to 1993, Horvitz held various positions at Magainin Pharmaceuticals Inc., now Genaera Corporation, where he last served as executive director, finance and human resources.